An interventional study of Stannous Fluoride Toothpaste (SnF) and Sodium Fluoride Dentifrice in Dental Plaque, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.
Sponsored by Church & Dwight Company, Inc. · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Dental Plaque with a site in United States — 7 open to participants now, 8 under way, 1 of them phase 3. Dental Plaque · United States.
Among the 65 studies in Dental Plaque with a site in United States, this one is the 22nd largest by enrollment of the 59 interventional ones that give a count, is one of 5 that started in 2024, is one of 33 with no phase, and was the 57th registered.
352 studies on the registry are indexed under Dental Plaque; 60 are open to participants now.
Browse Dental Plaque studies →7 of the 65 studies in Dental Plaque with a site in United States are open now. Recruiting first, the newest first:
Flaus, Inc · Sites in United States
Ages 18–70 · Healthy volunteers
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18–70
Lactea Therapeutics, LLC · Sites in United States
Ages 18–65 · Healthy volunteers
University of Nebraska · Sites in United States
Ages 19–85 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18–85 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 35 Dental Plaque studies recruiting now, 10 (29%) set no upper age limit and 20 (57%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.
This study: 18 Years to 69 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 5 · Phase 3 12 · Phase 4 4
First in 1998; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 91 is above the median of 56 across 316 interventional studies indexed under Dental Plaque.
Median enrollment 80 across the 59 interventional studies, 122 across the 6 observational. Of the 57 that completed or were terminated, 26 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
43 of 65 have an industry lead sponsor. The 10 most frequent:
Church & Dwight Company, Inc. is the lead sponsor of 33 studies on the registry; none are open to participants now.
Church & Dwight Company, Inc. has 5 studies filed under Dental Plaque — fewer than ten, so there is no comparison to draw.
3 of the studies in Dental Plaque with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07605338Phase 3Colgate PalmoliveTo Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis. | 2026-11 |
| NCT07706647The University of Texas Health Science Center at San AntonioOil Pulling Reduction | 2026-11-30 |
| NCT05384132University of Alabama at BirminghamNovel Dental Gel as an Adjunct to Scaling and Root Planing | 2027-10-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 65 studies in Dental Plaque with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized, stratified, double-blind, two-cell parallel clinical study evaluated the dental plaque prevention efficacy of a stannous fluoride toothpaste compared to a sodium fluoride control toothpaste following a professional dental prophylaxis. Adult subjects brushed twice daily for 14 days with their assigned dentifrice. Plaque was assessed using the Lobene-Soparkar modification of the Turesky Modification of the Quigley-Hein Plaque Index at baseline, Day 1, and Day 14 following periods of oral hygiene abstention.
This two-week, randomized, double-blind, parallel-group study evaluated plaque prevention following dental cleaning. Subjects meeting plaque qualification criteria underwent a complete prophylaxis and were randomized to either a stannous fluoride test dentifrice or a sodium fluoride control dentifrice. Subjects brushed twice daily for two minutes with the assigned product. Plaque accumulation was assessed at baseline, after one day of use, and after 14 days of use following overnight abstention from oral hygiene. Plaque was disclosed and scored on facial and lingual tooth surfaces using the Lobene-Soparkar modified Turesky Plaque Index. Treatment comparisons were performed using ANCOVA with baseline plaque as a covariate.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dentifrice containing sodium fluoride, serving as the control comparator.
Drug: Sodium Fluoride Dentifrice
Dentifrice containing stannous fluoride evaluated for plaque prevention compared to sodium fluoride control.
Drug: Stannous Fluoride Toothpaste (SnF)
Test toothpaste (0.454% SnF)
Comparator toothpaste (0.243% NaF)
Whole-Mouth Dental Plaque Score (Turesky Modified Quigley-Hein Index)
Mean whole-mouth plaque index score assessed using the Lobene-Soparkar modification of the Turesky Modification of the Quigley-Hein Plaque Index. Treatment comparisons performed using ANCOVA with baseline plaque score as a covariate.
Time frame: Day 14 (12 hours post-brushing following 14 days of twice-daily use)
Whole-Mouth Dental Plaque Score at Day 1
Mean whole-mouth plaque index score assessed one day after initial supervised brushing.
Time frame: Day 1 (12 hours post-brushing)
Plan to share: No — The sponsor does not plan to share individual participant data. Summary results will be provided as required, but no de-identified datasets will be made publicly available.
No publications or documents are linked to this record.
Ran from Oct 2024 to primary completion in Dec 2024, 1 month.
Of 45 industry-sponsored interventional studies with no phase under Dental Plaque, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 8. This study's 1 month is below that.
Counting every sponsor, half of 178 studies reached it within 6 months; a quarter within 2 and three quarters within 14.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tin Fluorides
Church & Dwight Company, Inc. →